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The inhibition by pertussis and tetanus toxins of evoked catecholamine 
release from intact and permeabilized bovine adrenal chromaffin cells 
~~~ind~~ K. Bansal, John H. Phillips and Simon van Heyningen 
Department of Biochemistry, University of Ediflburgh, Hugh Robson Building, George Square, Edinburgh EH8 9XD, UK 
Pertussis toxin stimulates both basat and nicotine-evoke catechofamine secretion from intact bovine adrenal chromathn eelfs, as we11 as Ca”- 
evoked release from permeabilized cells. Tetanus toxin inhibits all these effects; it reduces the secretion of intact cells treated with pert&s toxin 
to the basal level, and decreases by about 50% CP+-evoked release from permeabilized cells whether or not previously stimulated by pertussis 
toxin. 
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1. INTRQDUCTION 
Tetanus toxin is a potent neurotoxin that inhibits 
neurotransmitter elease at centraf inhibitory synapses, 
causing spastic paralysis. It is synthesised by C/OS&$- 
dium tetani as a single polypeptide chain (&& 150000). 
An active two-chain toxin consisting of heavy (ME 
100000) and light (50000) chains with an internal 
disulphide band is generated after subsequent pro- 
teolytic processing. The heavy chain binds to the outer 
plasma membrane of ceils, and this leads to the inter- 
nalization of the light chain [I]. Once internalized, the 
light chain probably catalyses a reaction which leads to 
the toxicity: it has been shown to be capable of in- 
hibiting exocytosis of catecbol~ines when introduced 
direct& into pe~eabi~ized adrenal chromaffin cells 
[2,3]. Tetanus toxin shares this two-component struc- 
ture with other bacteria1 toxins such as diphtheria toxin 
[4] and botulinurn toxin [S], The binding of the heavy 
chain to gangliosides and other receptors on the cell sur- 
face is well established @f, but how the internalized 
Light chain then inhibits neurotransmitter release is not 
clear. 
intracellular free [Ca’*], nor 4sCa2’ uptake [I l]! but it 
does markedly increase the affinity of exocytosis for 
CaZf IS], suggesting that G-proteins are involved in the 
direct control of Ca2+-sensitive exocytosis in these cells. 
In this paper, we report the effect of tetanus toxin on 
pertussis-stimulated catecholamine release by adrenal 
chromaffin cells. Our results indicate that tetanus toxin 
does not block exocytosis by affecting G-proteins, and 
that it might have a target at or near the plasma mem- 
brane affecting the movement of granules to the adja- 
cent active release sites and/or fusion of granules to the 
membrane. 
2. MATERIALS AND METHODS 
Pertussis toxin has recently been shown to stimuIate 
both nicotine- and high [VI-evoked release of cate- 
cholamines in chromaffin cells 17-91. There are three G- 
proteins (of M, 4f 000, 40~ and 39000) that are 
specifically ADP-ribosylated by pertussis toxin in 
adrenal chromaffin cells [IO], but the acquisition of this 
hyper-responsiveness to secretagogues was coincident 
with the toxin-catalysed ADP-ribosylation of only one 
of them @Jr 40000) [S]. Pertussis toxin affects neither 
Bovine adrenal cbromaffin cells were isolated from adrenai 
medullae by protease and collagenase digestion [12]. The cells were 
plated in 24-well multiwell plates (Gibco) at 0.5 x IO6 cells per well, 
and maintained in Dulbecco’s Modified Eagles medium containing 15 
mM Htpes, pH 7.4, supplemented with 10% foetal calf serum, 100 
units penicilfin and streptomycin/mi, SO pg gentamy&jn/ml, 0.25 pg 
fungizoneimf (Gibco) and 50 agiml ascorbic acid, at 37°C in a CUz 
incubator for 3 days. The medium was changed on day 3 to Dulbec- 
co’s Modified Eagles medium as above but without foetal calf serum, 
and the cells were maintained in culture for 4-7 days. 
2.2. Catecholamine release experiments 
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The cells were incubated with different concentrations of pertussis 
toxin (from the PHLS Centre for Applied ~~icrobioio~y and 
Research, Porton, W&hire, UK, and purified by the method of Irons 
and Gorringe ]13]) for different times as described below. The 
medium was removed and the cells were washed once with Locke’s 
solution (165 mM NaCI, 5.6 mM glucose, 5.0 mM Hepes, 2.2 mM 
CaC12, 1.2 mM MgSOa, pH 7.6). The cells were then stimulated with 
lOaM nicotine or 55 mM KCI in Locke’s sdution for 10 min at room 
temperature. The supernatant was removed and the cells were Iysed 
with 1% T&on X-100. Ahquots of the supernatant and the Triton 
fraction were assayed fluorimetrically for total catecholamine 
(adrenaline and noradrenaline) [141. 
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Fig. 1. The effect of pertussis toxin on basal and secretagogue- 
induced catecholamine r lease. Cells were incubated for 20 h with 0.9 
nM pertussis toxin (hatched bars) or without toxin (solid bars). 1OpM 
nicotine, 55 mM KCI, or Locke’s solution without secretagogue was 
added to the cells for 10 min, and the amount of catecholamine releas- 
ed into the medium determined as a percentage of total cellular 
catecholamine. Values shown are means iz SD (n = 3). 
2.3. Permeabilization of chromaffin ceils 
The cells were permeabilized by incubation with 10 pM digitonin 
(Sigma) in medium containing 139 mM NaCI, 20 mM piperazine- 
NJ”-bis(2-ethanesulphonic acid), 2 mM MgATP, 5 mM EGTA, pH 
6.6, with or without 0.7 PM tetanus toxin (a gift from Dr U. Weller 
of the Justus-Liebig-Universit~t, Giessen) for 16 min [15]. The soht- 
tion was then replaced by a similar medium without digitonin or 
tetanus toxin, and with or without 10 pM free Ca*+ ions. The 
catecholamines released into this medium and the cell fraction were 
estimated fluorimetrically as described in the previous section. 
3. RESULTS 
Our initial results on the effect of pertussis toxin on 
the catecholamine release confirmed previous findings 
[7-91 that preincubation of intact cells with 0.9 nM per- 
tussis toxin resulted in the stimulation of nicotine- 
20 
1 
Fig. 2. The effect of pertussis toxin concentration on nicotine- 
induced catecholamine release. Cells were incubated for 20 h with 
various concentrations of pertussis toxin (9 to 9x 10-s nM). The 
graph shows the percentage of catecholamine released into the 
medium with (+) or without (a) challenge with 10~M nicotine for 10 
min. Results are shown as means + SD (n = 3). 
evoked exocytosis by 50% and K+-evoked exocytosis by 
70% (Fig. 1). The effect of the toxin on basal cate- 
cholamine release was the same; it was enhanced by 
70%. 
The dose dependency of stimulation of nicotine- 
evoked catecholamine release by pertussis toxin is 
shown in Fig. 2. The half-maximal effective concentra- 
tion of pertussis toxin (9x 10F4 nm) is similar to that 
previously reported by Tanaka et al. [7]. The stimula- 
tion of basal release by pertussis toxin is also dose- 
dependent (Fig. 2), but, although the concentration for 
half-maximal effect was also about 9 x 10V4 nM, rather 
higher toxin concentrations were required to reach the 
maximum effect. 
Cells maintained in culture with 0.18 nM pertussis 
toxin over various lengths of time showed a stimulation 
of nicotine-evoked catecholamine after a lag period of 
2-4 h, and a maximum stimulation of 60% after 6 h ex- 
posure (Fig. 3). This lag is presumably the time taken 
for the toxin to enter the cells and express its effect [ 161. 
The effect of pertussis toxin was not reversed even when 
the toxin had been removed from the medium for a two- 
day period (data not shown). 
Pertussis toxin also stimulated catecholamine release 
by 40% from cells that had been permeabilized with 
digitonin and were then treated with 10 hM Ca2’ 
(Fig. 4). Permeabilization of cells followed by incuba- 
tion with EGTA led to a variable background release of 
catecholamine, but even this was stimulated in the 
presence of the toxin. 
Our previous unpublished work and that of others 
[2,3] have shown that tetanus toxin inhibits Ca’+-sen- 
sitive catecho~amjne release from digitonin-perme- 
abilized cells. We therefore looked at the effect of 
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Fig. 3. A time course of catecholamine release induced by pertussis 
toxin. Cells were incubated with pertussis toxin (0.18 nM) for the in- 
dicated time intervals, and catecholamine r lease into the medium was 
measured after addition of nicotine. The released catecholamine was 
calculated as a percentage of total cellular content, and the results are 
shown as mean + SD (n=3). In the absence of pertussis toxin, 
10.2 t 0.6% of cellular catecholamine was released. 
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Fig. 4. The effect of tetanus toxin on pertussis-toxin-sensitive 
catecholamine release. Cells were incubated with 0.9 nM pertussis 
toxin for 20 h, then permeabilized with digitonin in the presence or 
absence of 0.7 pM tetanus toxin for I2 min. A solution with or 
without IOpM free Ca’+ ions was added to the cells for a further I5 
min, and the percentage catecholamine released into the medium 
determined. (A) control cells, no toxins; (B) pertussis toxin alone; (C) 
tetanus toxin alone; (D) pertussis toxin followed by tetanus toxin. The 
values presented here are shown as means + SD (n = 3). 
tetanus toxin on the stimulation of catecholamine 
release by pertussis toxin (Fig. 4). Cells were first in- 
cubated for 20 h with pertussis toxin (0.9 nM) and then 
permeabilized in the presence of tetanus toxin (0.7 pM) 
for I2 min. Tetanus toxin inhibited release under all 
conditions: Ca2+-sensitive r lease in the absence of per- 
tussis toxin was decreased by 50% and Ca2’-sensitive 
pertussis-stimulated release was decreased by 40070, 
while Ca2+ -insensitive pertussis-stimulated secretion 
was reduced to the basal level. Tetanus toxin thus in- 
hibits both Cazc-evoked release and the effect at- 
tributed to treatment with pertussis toxin. 
4. DISCUSSION 
Pertussis toxin has been found to have stimulatory 
effects on secretion in a variety of cells, such as insulin 
release induced by glucose in rat pancreatic islets [16], 
and growth hormone release induced by growth hor- 
mone releasing factor [17]. In this paper, we have 
shown that this pertussis stimulation of secretion in 
chromaffin cells is inhibited by tetanus toxin (a toxin 
that also inhibits secretion from untreated chromaffin 
cells). 
Stimulation by pertussis toxin of catecholamine 
secretion from chromaffin cells is likely to involve the 
ADP-ribosylation of one or more of the three GTP- 
binding proteins that are specifically ADP-ribosylated 
by the toxin [8, lo]. Modulation of the affinity for Ca2+ 
of the known target of pertussis toxin by a GTP-binding 
protein has been implicated in the direct control of ex- 
ocytosis [ 181. 
The mechanism by which tetanus toxin inhibits ex- 
ocytosis is not known. However, both our work (Fig. 3) 
and a recent demonstration [33 that tetanus toxin inter- 
nalized after permeabilizing the plasma membrane of 
chromaffin cells can block exocytosis favour an in- 
tracellular site of action. The inhibition of pertussis- 
toxin-stimulated catecholamine release by tetanus toxin 
reported here shows that the two toxins probably act at 
different sites, suggesting that tetanus toxin does not in- 
hibit exocytosis by affecting GTP binding proteins. Ex- 
periments in many laboratories, including our own, 
have failed to find any ADP-ribosylation catalyzed by 
tetanus toxin or by the related botulinum neurotoxin 
(e.g. 1181). This is further supported by the finding that 
tetanus toxin exerts its action in a few minutes in 
permeabilized cells which presumably lack the 
nucleotides needed for ADP-ribosylation. 
There is a difference in the time that the two toxins 
take to act in chromaffin cells. Our previous work 
showed that more than 16 h are required for tetanus 
toxin to inhibit exocytosis from these adrenal cells when 
they are intact (M.K. Bansal, C.A. Colville, J.H. 
Phillips and S. van Heyningen, manuscript in prepara- 
tion), yet the maximum effect of pertussis toxin is 
achieved after only about 4 h of incubation. It is not, of 
course, known whether the rate-limiting step is inter- 
nalization or the interaction of toxin with intracellular 
targets. 
The catecholamine that is secreted from normal cells 
in the absence of any secretagogue or from permabiliz- 
ed cells in the absence of Ca2+ ions is probably released 
from those granules that are already close to the plasma 
membrane. As an elevation of free [Ca2+] is known to 
regulate aspects of actin-filament organisation [19], a 
change in the structure of actin filaments may be re- 
quired in order to allow secretory granules access to the 
sites of exocytosis 1201. Pertussis toxin stimulates basal 
release even in the absence of Ca2+, indicating that its 
site of action may be distal to interactions between 
granules and the cytoskeleton, and showing that it is 
also possible that an as yet unidentified GTP-binding 
protein which acts to inhibit exocytosis may be present 
in chromaffin cells. The presence of substrates for per- 
tussis toxin in secretory granuies, as well as plasma 
membrane fractions, has been shown by Toutant et al. 
[lo], and it is possible that a similar reaction may occur 
physiologically, since proteins ADP-ribosylated at cys- 
teine residues (i.e. analogously to the action of pertussis 
toxin) have been found in the plasma membrane of liver 
cells [Zl]. The processing of vesicles for fusion during 
protein transport through the Golgi stack has been 
shown to involve a GTP-binding protein, suggesting a
possible role for G-proteins in membrane fusion events 
in general 1221. The inhibition of pertussis-toxin- 
stimulated basal release by tetanus toxin indicates that 
it might be interfering with the movement of synaptic 
vesicles to active release sites near the plasma mem- 
brane from closely adjacent positions, as suggested by 
167 
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Dreyer et al. [23], as well as affecting their fusion to the 
plasma membrane [24]. 
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